A change in the market - investing in diagnostics

被引：16
|
作者：
Batchelder, Keith [1 ]
Miller, Peter [1 ]
机构：
[1] Genom Healthcare Strategies, Charlestown, MA 02129 USA
来源：
NATURE BIOTECHNOLOGY | 2006年 / 24卷 / 08期
关键词：
D O I：
10.1038/nbt0806-922
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Low margins, tricky reimbursement issues and the difficulty of market penetration have traditionally made diagnostics unattractive to investors. However, with changes to healthcare economics, regulation and the adoption of companion diagnostic tests that are predictive for drug response, that may be about to change. © 2006 Nature Publishing Group.
引用
收藏
页码：922 / 926
页数：5
相关论文
共 50 条
12345